Halla Thorsteinsdottir
Affiliations: | University of Toronto, Toronto, ON, Canada |
Area:
Public Health, Canadian Studies, Health Care ManagementGoogle:
"Halla Thorsteinsdottir"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| León-de la O DI, Thorsteinsdóttir H, Calderón-Salinas JV. (2018) The rise of health biotechnology research in Latin America: A scientometric analysis of health biotechnology production and impact in Argentina, Brazil, Chile, Colombia, Cuba and Mexico. Plos One. 13: e0191267 |
| Thorsteinsdóttir H, Ovtcharenko N, Kohler JC. (2017) Corporate social responsibility to improve access to medicines: the case of Brazil. Globalization and Health. 13: 10 |
| Medina-Molotla N, Thorsteinsdóttir H, Frixione E, et al. (2017) Some factors limiting transfer of biotechnology research for health care at Cinvestav: A Mexican scientific center Technology in Society. 48: 1-10 |
| Phillips K, Kohler JC, Pennefather P, et al. (2013) Canada's neglected tropical disease research network: who's in the core-who's on the periphery? Plos Neglected Tropical Diseases. 7: e2568 |
| Ali-Khan SE, Ray M, McMahon DS, et al. (2013) Sino-Canadian collaborations in stem cell research: a scientometric analysis. Plos One. 8: e57176 |
| McMahon D, Thorsteinsdóttir H. (2013) Pursuing endogenous high-tech innovation in developing countries: A look at regenerative medicine innovation in Brazil, China and India Research Policy. 42: 965-974 |
| Thorsteinsdóttir H, Sáenz TW. (2012) History of science. Tackling meningitis in Africa. Science (New York, N.Y.). 338: 1546-7 |
| McMahon DS, Thorsteinsdóttir H. (2011) Making stem cells count for global health. Regenerative Medicine. 6: 163-6 |
| Thorsteinsdóttir H, Ray M, Kapoor A, et al. (2011) Health biotechnology innovation on a global stage. Nature Reviews. Microbiology. 9: 137-43 |
| Lander B, Thorsteinsdóttir H. (2011) Developing biomedical innovation capacity in India Science and Public Policy. 38: 767-781 |